IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 223 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.15 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $7,040 | +252.0% | 1,000 | +300.0% | 0.00% | +50.0% |
Q3 2022 | $2,000 | -33.3% | 250 | 0.0% | 0.00% | +100.0% |
Q2 2022 | $3,000 | -95.8% | 250 | -94.3% | 0.00% | -96.4% |
Q1 2022 | $72,000 | +60.0% | 4,350 | +85.1% | 0.03% | +40.0% |
Q4 2021 | $45,000 | -57.9% | 2,350 | -46.0% | 0.02% | -59.2% |
Q3 2021 | $107,000 | -3.6% | 4,350 | +2.4% | 0.05% | -7.5% |
Q2 2021 | $111,000 | -12.6% | 4,250 | +6.2% | 0.05% | -8.6% |
Q1 2021 | $127,000 | -31.4% | 4,000 | 0.0% | 0.06% | -31.8% |
Q4 2020 | $185,000 | +39.1% | 4,000 | -1.2% | 0.08% | +13.3% |
Q3 2020 | $133,000 | +19.8% | 4,050 | 0.0% | 0.08% | +8.7% |
Q2 2020 | $111,000 | -0.9% | 4,050 | 0.0% | 0.07% | -5.5% |
Q4 2019 | $112,000 | – | 4,050 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fairmount Funds Management LLC | 565,890 | $26,257,000 | 9.39% |
Consonance Capital Management LP | 1,710,803 | $79,381,000 | 7.41% |
GREAT POINT PARTNERS LLC | 917,427 | $42,569,000 | 6.91% |
Avoro Capital Advisors LLC | 7,500,000 | $348,000,000 | 5.99% |
Ghost Tree Capital, LLC | 500,000 | $23,200,000 | 5.17% |
FRAZIER MANAGEMENT LLC | 1,312,999 | $60,923,000 | 4.69% |
Perceptive Advisors | 9,166,304 | $425,316,000 | 4.56% |
Ally Bridge Group (NY) LLC | 360,000 | $16,704,000 | 2.86% |
Orbimed Advisors | 6,645,100 | $308,333,000 | 2.70% |
ACUTA CAPITAL PARTNERS, LLC | 164,800 | $7,647,000 | 2.08% |